Idexx Laboratories
(IDXX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 549,181 | 475,992 | 412,670 | 386,081 | 367,432 |
| Cost of Goods | 270,164 | 245,688 | 219,945 | 202,750 | 190,256 |
| Gross Profit | 279,017 | 230,304 | 192,725 | 183,331 | 177,176 |
| Operating Expenses | 171,146 | 150,605 | 127,855 | 127,529 | 124,181 |
| Operating Income | 108,035 | 80,387 | 65,815 | 56,552 | 53,251 |
| Interest Expense | 155 | 0 | 0 | 0 | 0 |
| Other Income | 3,223 | 2,867 | 2,955 | 2,229 | 4,996 |
| Pre-tax Income | 111,103 | 83,254 | 68,770 | 58,781 | 58,247 |
| Income Tax | 33,165 | 26,278 | 23,381 | 21,161 | 21,615 |
| Net Income Continuous | 78,332 | 57,090 | 45,389 | 37,620 | 36,632 |
| Net Income | $78,332 | $57,090 | $45,389 | $37,620 | $36,632 |
| EPS Basic Total Ops | 0.57 | 0.42 | 0.34 | 0.28 | 0.27 |
| EPS Basic Continuous Ops | 0.57 | 0.42 | 0.34 | 0.28 | 0.26 |
| EPS Diluted Total Ops | 0.55 | 0.40 | 0.33 | 0.27 | 0.26 |
| EPS Diluted Continuous Ops | 0.55 | 0.40 | 0.32 | 0.27 | 0.25 |
| EBITDA(a) | $126,462 | $99,284 | $85,939 | $78,781 | $72,732 |